Katarzyna Gębura

613 total citations
22 papers, 349 citations indexed

About

Katarzyna Gębura is a scholar working on Immunology, Hematology and Oncology. According to data from OpenAlex, Katarzyna Gębura has authored 22 papers receiving a total of 349 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Immunology, 8 papers in Hematology and 7 papers in Oncology. Recurrent topics in Katarzyna Gębura's work include Immunodeficiency and Autoimmune Disorders (4 papers), Multiple Myeloma Research and Treatments (4 papers) and Chronic Lymphocytic Leukemia Research (3 papers). Katarzyna Gębura is often cited by papers focused on Immunodeficiency and Autoimmune Disorders (4 papers), Multiple Myeloma Research and Treatments (4 papers) and Chronic Lymphocytic Leukemia Research (3 papers). Katarzyna Gębura collaborates with scholars based in Poland, Spain and United States. Katarzyna Gębura's co-authors include Katarzyna Bogunia‐Kubik, Jerzy Świerkot, Piotr Wiland, Barbara Wysoczańska, Lucyna Korman, Beata Nowak, Tomasz Wróbel, Grzegorz Mazur, Kazimierz Kuliczkowski and Justyna Rybka and has published in prestigious journals such as International Journal of Molecular Sciences, Annals of the Rheumatic Diseases and Nutrients.

In The Last Decade

Katarzyna Gębura

22 papers receiving 345 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Katarzyna Gębura Poland 12 145 89 88 73 66 22 349
Nishanthi Thalayasingam United Kingdom 7 103 0.7× 97 1.1× 98 1.1× 35 0.5× 31 0.5× 10 308
Shankar Revu United States 9 234 1.6× 88 1.0× 86 1.0× 33 0.5× 82 1.2× 14 404
Xiang-Pei Li China 6 209 1.4× 72 0.8× 82 0.9× 25 0.3× 55 0.8× 6 372
Laurindo Ferreira da Rocha Brazil 11 170 1.2× 119 1.3× 78 0.9× 32 0.4× 64 1.0× 17 377
Mahdi Vojdanian Iran 13 113 0.8× 145 1.6× 101 1.1× 61 0.8× 52 0.8× 31 353
Saloua Zrioual France 7 341 2.4× 179 2.0× 73 0.8× 102 1.4× 111 1.7× 8 520
Caixia Li China 9 207 1.4× 65 0.7× 90 1.0× 30 0.4× 25 0.4× 21 377
Riccardo Terenzi Italy 11 134 0.9× 186 2.1× 91 1.0× 58 0.8× 45 0.7× 23 393
Deborah Cluxton Ireland 5 284 2.0× 69 0.8× 101 1.1× 40 0.5× 60 0.9× 5 438

Countries citing papers authored by Katarzyna Gębura

Since Specialization
Citations

This map shows the geographic impact of Katarzyna Gębura's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Katarzyna Gębura with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Katarzyna Gębura more than expected).

Fields of papers citing papers by Katarzyna Gębura

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Katarzyna Gębura. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Katarzyna Gębura. The network helps show where Katarzyna Gębura may publish in the future.

Co-authorship network of co-authors of Katarzyna Gębura

This figure shows the co-authorship network connecting the top 25 collaborators of Katarzyna Gębura. A scholar is included among the top collaborators of Katarzyna Gębura based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Katarzyna Gębura. Katarzyna Gębura is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Trynda, Justyna, Eliza Turlej, Karolina Anna Mielko, et al.. (2022). Polymorphism of VDR Gene and the Sensitivity of Human Leukemia and Lymphoma Cells to Active Forms of Vitamin D. Cancers. 14(2). 387–387. 8 indexed citations
2.
Sochocka, Marta, et al.. (2022). Ginkgo Biloba Leaf Extract Improves an Innate Immune Response of Peripheral Blood Leukocytes of Alzheimer’s Disease Patients. Nutrients. 14(10). 2022–2022. 16 indexed citations
3.
Frydecka, Dorota, Gil Zalsman, Małgorzata Krzystek‐Korpacka, et al.. (2020). A pro-inflammatory phenotype is associated with behavioural traits in children with Prader–Willi syndrome. European Child & Adolescent Psychiatry. 30(6). 899–908. 10 indexed citations
5.
Wysoczańska, Barbara, Marta Dratwa, Katarzyna Gębura, et al.. (2019). <p>Variability within the human <em>TERT</em> gene, telomere length and predisposition to chronic lymphocytic leukemia</p>. OncoTargets and Therapy. Volume 12. 4309–4320. 15 indexed citations
6.
Maj, Ewa, Justyna Trynda, Katarzyna Gębura, et al.. (2019). Differential response of lung cancer cell lines to vitamin D derivatives depending on EGFR, KRAS, p53 mutation status and VDR polymorphism. The Journal of Steroid Biochemistry and Molecular Biology. 193. 105431–105431. 19 indexed citations
7.
Wróbel, Tomasz, Aleksandra Butrym, Piotr Łacina, et al.. (2017). bFGF Polymorphism Is Associated with Disease Progression and Response to Chemotherapy in Multiple Myeloma Patients. Anticancer Research. 37(4). 1799–1804. 4 indexed citations
8.
Gębura, Katarzyna, Jerzy Świerkot, Barbara Wysoczańska, et al.. (2017). Polymorphisms within Genes Involved in Regulation of the NF-κB Pathway in Patients with Rheumatoid Arthritis. International Journal of Molecular Sciences. 18(7). 1432–1432. 24 indexed citations
9.
Butrym, Aleksandra, Katarzyna Gębura, Milena Iwaszko, et al.. (2016). Dual role of the CXCL12 polymorphism in patients with chronic lymphocytic leukemia. HLA. 87(6). 432–438. 2 indexed citations
10.
Butrym, Aleksandra, Justyna Rybka, Piotr Łacina, et al.. (2015). Polymorphisms within beta-catenin encoding gene affect multiple myeloma development and treatment. Leukemia Research. 39(12). 1462–1466. 16 indexed citations
11.
Wróbel, Tomasz, Katarzyna Gębura, Barbara Wysoczańska, et al.. (2014). IL-17F gene polymorphism is associated with susceptibility to acute myeloid leukemia. Journal of Cancer Research and Clinical Oncology. 140(9). 1551–1555. 30 indexed citations
12.
Bogunia‐Kubik, Katarzyna, Jerzy Świerkot, Barbara Wysoczańska, et al.. (2014). IL-17A, IL-17F and IL-23R Gene Polymorphisms in Polish Patients with Rheumatoid Arthritis. Archivum Immunologiae et Therapiae Experimentalis. 63(3). 215–221. 68 indexed citations
13.
14.
Gębura, Katarzyna, Milena Iwaszko, Jerzy Świerkot, et al.. (2014). Significance of association of HLA-C and HLA-E with psoriatic arthritis. Human Immunology. 75(12). 1188–1191. 15 indexed citations
15.
Świerkot, Jerzy, Katarzyna Gębura, Barbara Wysoczańska, et al.. (2014). AB0762 Clinical Associations of the IL-17A, IL-17F and Nfkb-1 Gene Polymorphisms in Patients with Rheumatoid and Psoriatic Arthritis. Annals of the Rheumatic Diseases. 73. 1056–1057. 2 indexed citations
16.
Mazur, Grzegorz, Katarzyna Gębura, Anna Gieryng, et al.. (2013). The CXCL12-3′A allele plays a favourable role in patients with multiple myeloma. Cytokine. 64(1). 422–426. 11 indexed citations
17.
Wróbel, Tomasz, Grzegorz Mazur, Justyna Rybka, et al.. (2013). VEGF and bFGF gene polymorphisms in Polish patients with B-CLL. Medical Oncology. 30(1). 456–456. 7 indexed citations
18.
Wróbel, Tomasz, Grzegorz Mazur, Justyna Rybka, et al.. (2013). VEGFandbFGFGene Polymorphisms in Patients with Non-Hodgkin's Lymphoma. BioMed Research International. 2013. 1–6. 18 indexed citations
19.
Gębura, Katarzyna & Katarzyna Bogunia‐Kubik. (2012). Clinical relevance of chemokine receptor CXCR4. Postępy Higieny i Medycyny Doświadczalnej. 66. 252–266. 7 indexed citations
20.
Bogunia‐Kubik, Katarzyna, Anna Gieryng, Katarzyna Gębura, & Andrzej Lange. (2012). Genetic variant of the G-CSF receptor gene is associated with lower mobilization potential and slower recovery of granulocytes after transplantation of autologous peripheral blood progenitor cells. Cytokine. 60(2). 463–467. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026